Literature DB >> 3373427

Utilization of diethyl-beta-cyclodextrin as a sustained-release carrier for isosorbide dinitrate.

F Hirayama1, N Hirashima, K Abe, K Uekama, T Ijitsu, M Ueno.   

Abstract

Heptakis(2,6-di-O-ethyl)-beta-cyclodextrin (2) was prepared and its physicochemical properties, such as aqueous solubility and surface activity, were compared with those of beta-cyclodextrin (1) and heptakis(2,6-di-O-methyl)-beta-cyclodextrin (3). A possible utility of 2 as a sustained-release drug carrier was examined using a water-soluble drug, isosorbide dinitrate. The dissolution and release rates of isosorbide dinitrate from capsule and tablet forms were significantly retarded by the complexation with 2. The sustained-release pattern of isosorbide dinitrate was produced for a long period after the oral administration of a single dose of capsule or tablet containing the 2 complex to rats. The results indicated that 2 may serve as a hydrophobic drug carrier for sustained-release of isosorbide dinitrate.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3373427     DOI: 10.1002/jps.2600770310

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

Review 1.  Cyclodextrins in drug delivery: an updated review.

Authors:  Rajeswari Challa; Alka Ahuja; Javed Ali; R K Khar
Journal:  AAPS PharmSciTech       Date:  2005-10-14       Impact factor: 3.246

Review 2.  Advances in the use of functional composites of β-cyclodextrin in electrochemical sensors.

Authors:  Xiaohui Niu; Zunli Mo; Xing Yang; Mingyuan Sun; Pan Zhao; Zhenliang Li; Meixuan Ouyang; Zhenyu Liu; Huhu Gao; Ruibin Guo; Nijuan Liu
Journal:  Mikrochim Acta       Date:  2018-06-16       Impact factor: 5.833

3.  Preparation of heptakis(2,6-di-O-ethyl)-beta-cyclodextrin and its nuclear magnetic resonance spectroscopic characterization.

Authors:  F Hirayama; M Kurihara; Y Horiuchi; T Utsuki; K Uekama; M Yamasaki
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.